Zachrisson B F, Johansson R, Björk L
Rofo. 1980 Feb;132(2):208-11. doi: 10.1055/s-2008-1056552.
Two new contrast media, Amipaque (metrizamide, Nyegaard & Co A/S, Oslo) and Hexabrix (ioxaglic acid, Laboratoire Guerbet, Paris) were compared in a double blind study in patients with arterial insufficiency in the legs. The incidence of subjective adverse effects (pain and sensation of heat) was low and similar with both contrast agents. Also the effects on heart rate and blood pressure were small and transient and similar with both contrast agents.
在一项针对腿部动脉供血不足患者的双盲研究中，对两种新型造影剂——阿米培克（甲泛葡胺，Nyegaard & Co A/S，奥斯陆）和六异泛影葡胺（碘克沙酸，Laboratoire Guerbet，巴黎）进行了比较。主观不良反应（疼痛和热感）的发生率较低，且两种造影剂相似。此外，两种造影剂对心率和血压的影响均较小且短暂，也是相似的。
